Skip to content

SCHEDULE 13D/AAccepted Jul 6, 9:35 PM ET

Abivax S.A. SCHEDULE 13D/A

Sofinnova Crossover I

Accepted (ET)

9:35 PM

Jul 6, 2026

Filed

Jul 6, 2026

Documents

1

Size

26.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.